Skip to main content
Premium Trial:

Request an Annual Quote

AltheaDx Teams with Institute on Pediatric Cancer MDx

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – AltheaDx today said that it will collaborate with the Nicholas Conor Institute for Pediatric Cancer Research on developing molecular diagnostic tests for pediatric cancer.

The San Diego-based firm, which is developing microarray-based genetic tests, said that the collaboration will upon its existing test for diagnosis of multiple pediatric tumor types, and expand the test beyond diagnosis to prognosis and therapeutic monitoring. It said that the goal of the alliance is to create a single genetic panel from a single biopsy that will diagnose and inform treatment.

The Nicholas Conor Institute is a San Diego-based non-profit focused on finding new diagnostics and treatments for pediatric cancer.

The partners noted that they are currently seeking funding to cover the development costs of the program.

As reported last week by GenomeWeb Daily News, AltheaDx recently raised $6 million in a Series A round of equity financing.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.